Racial Differences in Prostate Cancer Aggressiveness and Metformin

Metformin, an inexpensive FDA approved diabetes drug, has been recently re-purposed as a treatment for prostate cancer. It has been associated with a reduced incidence of prostate cancer and improved prostate cancer outcomes. 

Recent questions have risen asking whether race modifies the association between metformin use and prostate cancer aggressiveness.